EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Skeletal Muscle Metastasis in Patients With SMARCA4 ‐Deficient Thoracic Tumors: A Retrospective Cohort Study

Xueyuan Chen iD, Mengting Shi, Yuwen Yang, Lin Zhang, Tingting Liu iD, Bijing Xiao, Silang Mo, Yuanzheng Ma, Gang Chen iD, Ting Zhou iD, Yunpeng Yang, Zhixiong Lin und 1 weitere

International Journal of Cancer · 15.09.2026 · 159 (6) · 1546-1555

DOI: 10.1002/ijc.70537 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, online erschienen am 04.05.2026. Verfasst von Xueyuan Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Sun Yatsen University Cancer Center, Guangzhou, China. Hauptthemen laut MEDLINE: Muscle Neoplasms, Nuclear Proteins, Thoracic Neoplasms, Transcription Factors. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chinese National Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SMARCA4‐deficient thoracic tumor (SDTT) is a malignant tumor with a poor prognosis that often presents with distant metastases at the time of clinical diagnosis. Skeletal muscle metastasis is a rare subtype of metastasis patterns, and there are limited studies about SDTT metastasis in skeletal muscle. Herein, we retrospectively analyzed the data of stage IV patients diagnosed with SDTT from May 2009 to June 2024. The clinical and genomic data, imaging features, and treatment information were collected. As a result, the study included 145 patients with metastatic SDTT, 17 with skeletal muscle metastases, and 128 without. The rate of skeletal muscle metastasis in SDTTs was 11.7%. Multivariate Cox regression analysis showed that skeletal muscle metastases ( p = 0.014, hazard ratio 95% confidence interval [HR 95% CI] [2.90, 1.25–6.75]) and first‐line chemoimmunotherapy ( p < 0.001, HR 95% CI [0.31, 0.17–0.56]) were independent prognostic variables. Furthermore, patients with skeletal muscle metastases had a significantly shorter median overall survival (OS) than those without (13.20 vs. 18.6 months, p = 0.021) in metastatic SDTTs. The mutation rate of STK11 and KRAS was higher in the skeletal muscle metastasis group (62.50% vs. 15.52%, p = 0.008; 50.00% vs. 8.62%, p = 0.009). In conclusion, SDTTs exhibited a high rate of skeletal muscle metastases. Skeletal muscle metastases and first‐line chemoimmunotherapy were independent prognostic factors for OS in SDTTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle NeoplasmsNuclear ProteinsThoracic NeoplasmsTranscription FactorsMuscle, SkeletalDNA HelicasesHumansFemaleRetrospective StudiesMaleMiddle AgedPrognosisAdultAged

Stichwörter der Autor:innen

SMARCA4‐deficient thoracic tumorschemoimmunotherapygenomic featureprognosisskeletal muscle metastasis

Substanzen

SMARCA4 protein, humanNuclear ProteinsTranscription FactorsDNA Helicases

Autor:innen und Institutionen

  • Department of Medical Oncology, Sun Yatsen University Cancer Center, Guangzhou, China.
  • State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
  • Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
  • Shantou University Medical College, Shantou, China.

ORCID-Profile: Xueyuan Chen, Tingting Liu, Gang Chen, Ting Zhou, Yuanyuan Zhao

Förderung

  • Chinese National Natural Science Foundation Project

Zitieren

APA

Chen, X., Shi, M., Yang, Y., Zhang, L., Liu, T., Xiao, B., Mo, S., Ma, Y., Chen, G., Zhou, T., Yang, Y., Lin, Z., & Zhao, Y. (2026). Skeletal Muscle Metastasis in Patients With SMARCA4 ‐Deficient Thoracic Tumors: A Retrospective Cohort Study. International Journal of Cancer, 159(6), 1546-1555. https://doi.org/10.1002/ijc.70537

Vancouver

Chen X, Shi M, Yang Y, Zhang L, Liu T, Xiao B, et al. Skeletal Muscle Metastasis in Patients With SMARCA4 ‐Deficient Thoracic Tumors: A Retrospective Cohort Study. International Journal of Cancer. 2026;159(6):1546-1555. doi:10.1002/ijc.70537

BibTeX
@article{Chen2026,
  author = {Chen, Xueyuan and Shi, Mengting and Yang, Yuwen and Zhang, Lin and Liu, Tingting and Xiao, Bijing and Mo, Silang and Ma, Yuanzheng and Chen, Gang and Zhou, Ting and Yang, Yunpeng and Lin, Zhixiong and Zhao, Yuanyuan},
  title = {Skeletal Muscle Metastasis in Patients With SMARCA4 ‐Deficient Thoracic Tumors: A Retrospective Cohort Study},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {6},
  pages = {1546--1555},
  doi = {10.1002/ijc.70537}
}
Kostenlos starten →